EssilorLuxottica Total Long Term Liabilities 2011-2024 | ESLOY

EssilorLuxottica total long term liabilities for the quarter ending December 31, 2024 were $10.793B, a 9.63% decline year-over-year.

  • EssilorLuxottica total long term liabilities for 2024 were $13.75B, a 6.84% increase from 2023.
  • EssilorLuxottica total long term liabilities for 2023 were $12.87B, a 9.69% decline from 2022.
  • EssilorLuxottica total long term liabilities for 2022 were $14.25B, a 17% decline from 2021.

EssilorLuxottica Total Long Term Liabilities 2011-2024 | ESLOY

  • EssilorLuxottica total long term liabilities for 2024 were $13.75B, a 6.84% increase from 2023.
  • EssilorLuxottica total long term liabilities for 2023 were $12.87B, a 9.69% decline from 2022.
  • EssilorLuxottica total long term liabilities for 2022 were $14.25B, a 17% decline from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$218.9B
Boston Scientific (BSX)$159.4B
Stryker (SYK)$153B
Medtronic (MDT)$118B
Lonza Group Ag (LZAGY)$50.9B
Haleon (HLN)$43.8B
ResMed (RMD)$40.1B
GE HealthCare Technologies (GEHC)$35.4B
Agilent Technologies (A)$33.9B
Terumo (TRUMY)$25.3B
Koninklijke Philips (PHG)$24.9B
Insulet (PODD)$20.2B
Zimmer Biomet Holdings (ZBH)$19.3B
Baxter (BAX)$14.7B
Smith & Nephew SNATS (SNN)$13.9B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$7B
Lantheus Holdings (LNTH)$5.1B
Perrigo (PRGO)$3.9B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.2B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.8B
AtriCure (ATRC)$1.5B
Acuren (TIC)$1.4B
AdaptHealth (AHCO)$1.3B